Faculty & Research
Overview
Faculty & research are integral components of BME. With a strong focus on research, BME is located in the heart of Canada’s largest health-care research hub. Our 300 graduate students receive their training from 14 departments at U of T, 10 partner hospitals, and 7 research institutes & commercialization centres.
At BME, our cross-disciplinary approach in biomedical and clinical engineering enables our researchers to cover a diverse set of topics. Find out what our research publication are saying about our research focus.
Faculty directory
Core Faculty
We have 30+ core faculty members that span across cell & tissue engineering, clinical engineering, and molecular engineering disciplines.
Cross-Appointed Faculty
BME currently hosts cross-appointed faculty members across more than 30 academic units, partner hospitals, research institutes, and commercialization centres.
Emeriti
Learn about some of our retired faculty members
Research streams
Clinical
BME’s clinical engineers design technologies, devices and strategies for people with chronic disease, traumatic injury, disabilities and mobility limitations to help them integrate more fully with their environment.
Cell & Tissue
Research that has the potential to change how we think about disease and aging is happening at BME. Regenerative medicine uses stem cells and biomaterials to repair, replace or regenerate damaged tissue, organ structures and function.
Molecular
BME researchers are advancing disease detection, customizing drug delivery and improving health-care outcomes with faster and more precise technologies and systems.
Latest news
September 19, 2022 | The Donnelly Centre is swelling its ranks of leading researchers with two new faculty appointments.
September 13, 2022 | KITE Scientist Dr. Alex Mihailidis experienced the rehab system first-hand after a devastating spinal cord injury. The ordeal altered how his team works with patients and clinicians.
September 1, 2022 | Dr. Omar Khan is one of four researchers are the latest to receive support to spin-off aspects of their Medicine by Design-funded research into an early-stage product or venture as part of Medicine by Design’s Pivotal Experiment Fund, which has distributed more than $2.5-million in funding since its launch in early 2021.
August 18, 2022 | A U of T Engineering research team has created a new platform that delivers multiple therapeutic proteins to the body, each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50.
July 28, 2022 | A team of U of T Engineering researchers, led by Professor Molly Shoichet (ChemE, BME, Donnelly), has designed a new way to grow cells in a laboratory that enables them to better emulate cancerous tumours.
